| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 03/30/2010 | CA2229479C Method of promoting angiogenesis |
| 03/25/2010 | WO2010034011A2 Phenylthiophenyldihydrobenzothiazepine inhibitors of store operated calcium release |
| 03/25/2010 | WO2010034003A2 Benzylthiotetrazole inhibitors of store operated calcium release |
| 03/25/2010 | WO2010033292A2 Method for medical treatment utilizing l-glutathione |
| 03/25/2010 | WO2010033074A1 Use of a tlr7 agonist for the treatment of cancer |
| 03/25/2010 | WO2010031589A1 Small molecule bradykinin b2 receptor modulators |
| 03/25/2010 | WO2010013110A3 Composition comprising estrone and hydrocortisone for use in the topical treatment of baldness |
| 03/25/2010 | WO2010013078A3 Pyrrolidinyl-alkyl-amide derivatives their preparation and their therapeutic application as ccr3 receptor ligands |
| 03/25/2010 | WO2010009405A9 Targeted nitroxide agents |
| 03/25/2010 | WO2010008733A3 Solid forms of (1r,2s,3r)-1-(2-(isoxazol-3-yl)-1h-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use |
| 03/25/2010 | WO2010007502A3 Platelet fraction deriving from placental blood |
| 03/25/2010 | WO2010006123A3 19-nor-vitamin d analogs with 1,2-dihydrofuran ring |
| 03/25/2010 | WO2010006121A3 19-nor-vitamin d analogs with 3,2-dihydrofuran ring |
| 03/25/2010 | WO2009154396A3 Sustained releasing preparation comprising a crude drug extract for preventing moisturization and controlled release |
| 03/25/2010 | WO2009138583A3 Use of a composition containing ergosterol or a natural extract of a vegetable or animal microorganism |
| 03/25/2010 | WO2009137074A9 Compositions and methods for treating diabetic ulcers |
| 03/25/2010 | WO2009111083A3 In vivo temporal control of activ at able matrix- degrading enzymes |
| 03/25/2010 | WO2009106555A3 Sterilized sucralfate gel |
| 03/25/2010 | WO2009074793A3 Methods for the inhibition of scarring |
| 03/25/2010 | US20100076094 Formulation containing phosphate derivatives of electron transfer agents |
| 03/25/2010 | US20100076077 Esters of 4,5-disubstituted-oxy-2-methyl-3,6-dioxo-cyclohexa-1,4-dienyl alkyl acids and preparation thereof |
| 03/25/2010 | US20100076076 Novel palladium complexes inhibit n-myristoyltransferase activity in vitro and cancer growth in vivo |
| 03/25/2010 | US20100076068 Aminoalcohol Derivatives and Their Therapeutic Use |
| 03/25/2010 | US20100076065 Vitamin d receptor modulators |
| 03/25/2010 | US20100076031 Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis |
| 03/25/2010 | US20100076029 Compounds Which Selectively Modulate The CB2 Receptor |
| 03/25/2010 | US20100076024 Novel Compounds as Serine Protease Inhibitors |
| 03/25/2010 | US20100075989 Novel Compounds Having Selective Inhibiting Effect at GSK3 |
| 03/25/2010 | US20100075986 Oxophenyl-Cyclohexyl-Propanolamine Derivatives, Production And Use Thereof In Therapeutics |
| 03/25/2010 | US20100075923 Method of enhancing tgf-beta signalling |
| 03/25/2010 | US20100075898 N-terminal vdac variants and uses thereof |
| 03/25/2010 | US20100074880 Polyethylene glycol derivative |
| 03/25/2010 | US20100074878 Probiotic bacterium: lactobacillus fermentum |
| 03/25/2010 | US20100074857 Compositions and methods to treat epithelial-related conditions |
| 03/25/2010 | US20100074856 External preparation composition |
| 03/25/2010 | US20100074851 Cosmetic or pharmaceutical composition containing hyaluronic acid |
| 03/24/2010 | EP2166095A2 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes in endothelial cells |
| 03/24/2010 | EP2166010A1 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| 03/24/2010 | EP2166009A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 03/24/2010 | EP2166008A1 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| 03/24/2010 | EP2165704A1 Use of alverine for the treatment of cutaneous affections |
| 03/24/2010 | EP2165698A1 Cosmetic composition designed to protect damaged skin |
| 03/24/2010 | EP2165198A2 Cosmetic use of apolipoprotein d type proteins |
| 03/24/2010 | EP2164858A1 Novel compounds, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same |
| 03/24/2010 | EP2164845A1 Novel 4-heteroaryl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology |
| 03/24/2010 | EP2164828A2 Compounds as crth2 and/or pgd2 receptors modulators and their use for treating asthma and allergic inflammation |
| 03/24/2010 | EP2164827A2 Novel derivatives of 3-phenyl acrylic acid activating ppar-type receptors, method for preparing same and use thereof in cosmetic or pharmaceutical compositions |
| 03/24/2010 | EP2164502A1 Use of wf10 for treating allergic asthma, allergic rhinitis and atopic dermatitis |
| 03/24/2010 | EP2164500A1 The use of zeburaline for the treatment of autoimmune diseases or immune rejection of transplants |
| 03/24/2010 | EP2164486A2 Use of 4-phenyl-imidazole-2-thiones as tyrosinase inhibitors for preparing pharmaceutical or cosmetic compositions for treating or preventing pigment disorders |
| 03/24/2010 | CN101680008A Hydroxybenzyl or hydroxypyranonemethyl esters as tyrosinase inhibitors |
| 03/24/2010 | CN101679470A Method for production of sugar oxazoline derivative |
| 03/24/2010 | CN101679447A pyrimidodiazepinone derivative |
| 03/24/2010 | CN101679428A Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases |
| 03/24/2010 | CN101679388A Novel 4-heteroaryl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology |
| 03/24/2010 | CN101679293A Urocanic acid derivatives useful for the treatment of immune-related and inflammatory diseases |
| 03/24/2010 | CN101678036A Novel active ingredient in cicatrization and use thereof |
| 03/24/2010 | CN101678003A Use of biotin to prevent photoaging |
| 03/24/2010 | CN101678000A Use of 4-phenyl-imidazole-2-thiones as tyrosinase inhibitors for preparing pharmaceutical or cosmetic compositions for treating or preventing pigment disorders |
| 03/24/2010 | CN101677931A Wrinkling-preventing and -modifying agent |
| 03/24/2010 | CN101677583A Lactobacillus helveticus bacterium composition for treatment of atopic dermatitis |
| 03/24/2010 | CN101676319A Medical sodium hyaluronate gel for injection |
| 03/24/2010 | CN101675986A Lupus III traditional Chinese medicine composition |
| 03/24/2010 | CN101675969A A traditional Chinese medicinal ointment for treating allergic dermatitis |
| 03/24/2010 | CN101675967A Lupus I traditional Chinese medicine composition |
| 03/24/2010 | CN101675966A Medicament for treating psoriasis |
| 03/24/2010 | CN101675960A Lupus II traditional Chinese medicine composition |
| 03/24/2010 | CN101675953A Traditional Chinese medicine composition for treating psoriasis and its preparation method |
| 03/24/2010 | CN101675938A Preparation method and use of a novel peptide type immunizing agent whole-egg protein peptide |
| 03/24/2010 | CN101675927A therapeutic molecules and methods-1 |
| 03/24/2010 | CN101675922A Parakeratosis inhibitor, pore-shrinking agent and skin preparation for external use |
| 03/24/2010 | CN100595211C Angiopoietin-2 specific binding agents |
| 03/24/2010 | CN100594935C Antibodies that immunospecifically bind to trail receptors |
| 03/24/2010 | CN100594917C Externally applied medicine for curing psoriasis and producing method thereof |
| 03/24/2010 | CN100594912C Preparation of beauty gel for treating acne and preparing method |
| 03/24/2010 | CN100594911C Medicine composition and use |
| 03/24/2010 | CN100594908C Triamcinolone benetonide local film forming gel composition |
| 03/24/2010 | CN100594904C Hydrochloride epinastine dispersing tablets and their production |
| 03/24/2010 | CN100594883C Agent for treating alopecia and the preparing method thereof |
| 03/23/2010 | US7683164 Nucleic acid derivatives |
| 03/23/2010 | US7683074 Antiinflammatory agents; antiallergens; neurodegrative disease ; autoimmune disease; antiarthritic agents |
| 03/23/2010 | US7683061 rheumatoid arthritis, systemic lupus erythematosus (SLE), idiopathic (immune) thrombocytopenia (ITP), glomerulonephritis and vasculitis; reduced drug toxicity |
| 03/23/2010 | US7683034 Use of enzyme inhibitors of aminopeptidase N and/or dipeptidylpeptidase IV |
| 03/23/2010 | US7682623 Pharmaceutical composition for topical application |
| 03/23/2010 | US7682620 Oil-containing biliquid foam dispersed in a salt-containing aqueous phase having a pH of less than about 7, is gelled by a polymeric sulfonic acid, e.g., ammonium acrylamidopropanesulfonic acid-vinylformamide copolymer |
| 03/23/2010 | US7682387 Drug-delivery endovascular stent and method for treating restenosis |
| 03/23/2010 | CA2607237C The use of free radical scavengers for protecting and treating skin and hair damages caused by chemotherapy |
| 03/23/2010 | CA2555741C Method of stimulating hair growth |
| 03/23/2010 | CA2460177C 3-substituted-4-pyrimidone derivatives |
| 03/23/2010 | CA2446059C Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes |
| 03/23/2010 | CA2418652C Novel 3-substituted urea derivatives and medicinal use thereof |
| 03/23/2010 | CA2399405C 5-aminolevulinic acid formulation dissolved/dispersed in non-aqueous solvents |
| 03/23/2010 | CA2395283C Use of an extract of at least one plant of genus vaccinium as antiglycation agent |
| 03/23/2010 | CA2389767C Quinazoline derivatives as vegf inhibitors |
| 03/23/2010 | CA2358457C Topical composition comprising n-acetylaldosamines or n-acetylamino acids |
| 03/23/2010 | CA2346869C Phospholipid derivatives of non-steroidal anti-inflammatory drugs |
| 03/18/2010 | WO2010029930A1 Stable pharmaceutical formulation with limited discoloration |
| 03/18/2010 | WO2010029364A1 Compounds |
| 03/18/2010 | WO2010028652A1 Colostrum composition |
| 03/18/2010 | WO2010028596A1 The pharmaceutical composition containing ferulic acid and matrine compounds, the preparation and the use thereof |